Literature DB >> 11728697

Constitutive NF-kappaB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines.

C Didelot1, M Barberi-Heyob, A Bianchi, P Becuwe, J F Mirjolet, M Dauça, J L Merlin.   

Abstract

PURPOSE: Nuclear factor-kappaB (NF-kappaB) has been implicated in anti-apoptotic gene transactivation, according to its transcriptional activity. The present study was designed to investigate whether constitutive NF-kappaB activity could modulate basal apoptosis and intrinsic radiosensitivity of KB head-and-neck carcinoma cell line and KB3 subline. The KB3 subline was more radiosensitive (SF2 = 0.48, alpha = 0.064) than the radioresistant KB parental cell line (SF2 = 0.80, alpha = 0.114). METHODS AND MATERIALS: Constitutive NF-kappaB DNA-binding activity was determined using electrophoretic mobility shift assay. Modulation of NF-kappaB activity was performed by exposing both cell lines to tumor necrosis factor alpha or dexamethasone. Apoptotic cell population was analyzed using flow cytometry (annexin V/propidium iodide). Radiosensitivity was assessed from determination of the surviving fraction at 2 Gy (SF2), and alpha and beta parameters were determined using the linear-quadratic model.
RESULTS: Constitutive NF-kappaB activity was found to be significantly lower in KB3 than in KB. KB cell line exposure to dexamethasone significantly decreased NF-kappaB DNA-binding activity and, consequently, enhanced baseline apoptosis and radiosensitivity (alpha values: 0.114 vs. 0.052). Conversely, exposure of KB3 cells to tumor necrosis factor alpha increased NF-kappaB DNA-binding activity and resulted in a significant decrease (50%) in rate of apoptosis and in radiosensitivity (SF2 values: 0.48 vs. 0.63).
CONCLUSIONS: Modulation of NF-kappaB DNA-binding activity influences baseline apoptosis and intrinsic radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728697     DOI: 10.1016/s0360-3016(01)02608-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Association of nuclear factor κB expression with a poor outcome in nasopharyngeal carcinoma.

Authors:  Y Zhang; J Y Lang; L Liu; J Wang; G Feng; Y Jiang; Y L Deng; X J Wang; Y H Yang; T Z Dai; G Xie; J Pu; X B Du
Journal:  Med Oncol       Date:  2010-05-25       Impact factor: 3.064

Review 2.  Targeting inflammatory pathways for tumor radiosensitization.

Authors:  Amit Deorukhkar; Sunil Krishnan
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

3.  Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.

Authors:  Bert H O'Neil; William K Funkhouser; Benjamin F Calvo; Michael O Meyers; Hong Jin Kim; Richard M Goldberg; Stephen A Bernard; Laura Caskey; Allison M Deal; Fred Wright; Albert S Baldwin; Joel E Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-12       Impact factor: 7.038

Review 4.  Mitochondria and energetic depression in cell pathophysiology.

Authors:  Enn Seppet; Marju Gruno; Ants Peetsalu; Zemfira Gizatullina; Huu Phuc Nguyen; Stefan Vielhaber; Manfred H P Wussling; Sonata Trumbeckaite; Odeta Arandarcikaite; Doreen Jerzembeck; Maria Sonnabend; Katharina Jegorov; Stephan Zierz; Frank Striggow; Frank N Gellerich
Journal:  Int J Mol Sci       Date:  2009-05-19       Impact factor: 6.208

5.  Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells.

Authors:  Hiroshi Sugano; Yoshihiro Shirai; Takashi Horiuchi; Nobuhiro Saito; Yohta Shimada; Ken Eto; Tadashi Uwagawa; Toya Ohashi; Katsuhiko Yanaga
Journal:  Cancers (Basel)       Date:  2018-10-17       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.